[Stage CDC C3 HIV infection; V.a. acute serotoninergic syndrome].
Tietz
A
A
Medizinische Universitätspoliklinik, Kantonsspital Basel.
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis* / Q000188:drug therapy; D000328:Adult; D015283:Citalopram / Q000009:adverse effects* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D019469:Indinavir / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D009422:Nervous System Diseases / Q000139:chemically induced* / Q000175:diagnosis; D012701:Serotonin / Q000502:physiology*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D013577:Syndrome
D015283:Citalopram; D017320:HIV Protease Inhibitors; D019469:Indinavir; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors